AR
BCRX icon

Advisory Research’s BioCryst Pharmaceuticals BCRX Stock Holding History

Advisory Research’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-80,482
Closed -$1.31M – 376
2022
Q1 		$1.31M Buy
+80,482
New +$1.31M 0.1% 156